Collectively, our data support the view that monoclonal CD8+ TCR-Vβ+ expansions in T-LGLL patients arise in response to chronic antigen-driven stimulation and then acquire somatic mutations that provide further survival advantages (Fig. 7A). The gene discussed is CD8A; the disease is T-cell large granular lymphocyte leukemia.